financetom
Business
financetom
/
Business
/
--Microsoft-Backed OpenAI Expects Revenue to Triple in 2025 to $12.7 Billion, Bloomberg Reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Microsoft-Backed OpenAI Expects Revenue to Triple in 2025 to $12.7 Billion, Bloomberg Reports
Mar 26, 2025 11:50 AM

02:30 PM EDT, 03/26/2025 (MT Newswires) --

Price: 390.42, Change: -4.75, Percent Change: -1.20

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kalaris Posts Positive Results from Macular Degeneration Drug Trial
Kalaris Posts Positive Results from Macular Degeneration Drug Trial
Mar 10, 2026
05:50 PM EST, 12/17/2025 (MT Newswires) -- Kalaris Therapeutics ( KLRS ) reported late Wednesday positive initial data from its Phase 1a trial of its investigational drug for treating naive neovascular AMD patients. The single ascending dose (SAD) trial showed the drug candidate, TH103, had clinically meaningful improvements in vision and retinal anatomy. The trial also indicated early signs of...
DoorDash, OpenAI Partner to Offer Grocery Shopping App Inside ChatGPT
DoorDash, OpenAI Partner to Offer Grocery Shopping App Inside ChatGPT
Mar 10, 2026
05:47 PM EST, 12/17/2025 (MT Newswires) -- DoorDash ( DASH ) has teamed up with Microsoft ( MSFT )-backed OpenAI (MSFT) to offer a grocery-shopping app directly within ChatGPT, allowing users to convert recipes into food orders delivered from nearby stores. The partnership marks a shift toward agentic commerce, with AI acting as a personal assistant to handle shopping, payments,...
Royalty Pharma Insider Sold Shares Worth $766,420, According to a Recent SEC Filing
Royalty Pharma Insider Sold Shares Worth $766,420, According to a Recent SEC Filing
Mar 10, 2026
05:47 PM EST, 12/17/2025 (MT Newswires) -- Marshall Urist, Executive Vice President, Research & Investments, on December 16, 2025, sold 20,000 shares in Royalty Pharma ( RPRX ) for $766,420. Following the Form 4 filing with the SEC, Urist has control over a total of 166,418 Class A ordinary shares of the company, with 7,398 shares held directly and 159,020...
Sweetgreen Chief Brand Officer to Retire
Sweetgreen Chief Brand Officer to Retire
Mar 10, 2026
05:45 PM EST, 12/17/2025 (MT Newswires) -- Sweetgreen ( SG ) said late Wednesday that Chief Brand Officer Nathaniel Ru will retire, effective Jan. 1, 2026. Ru will continue to serve as a board member, the company said. Zipporah Allen, who joined as chief commercial officer in September, has assumed Ru's responsibilities, the firm said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved